SIGY实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 03:42):

Stats
今日成交量	200.00
平均成交量	109.00
市值	8.17M
EPS	$-0.0200 ( 2023-11-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.760
ATR14	$0 (0.00%)

Sigyn Therapeutics, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Sigyn Therapeutics, Inc. 财务报表

Annual	2023
营收:	$0
毛利润:	$-8 856.00 (0.00 %)
EPS:	$-3.77

FY	2023
营收:	$0
毛利润:	$-8 856.00 (0.00 %)
EPS:	$-3.77

FY	2022
营收:	$0
毛利润:	$-10 454.00 (0.00 %)
EPS:	$-0.0993

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.409

Financial Reports:

No articles found.

Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company. It offers Sigyn Therapy, a blood purification technology to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths. The company also engages in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; CytoVesicles; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. The company is headquartered in San Diego, California.